BIOMAT Database Logo BIOMAT Database Logo

An overview of two comparative multicentre trials with halometasone/triclosan cream in acute superficial bacterial skin infections. 1983

A Aliaga, and A Castells, and D Kriznik, and J Lalosević, and J Marrón, and J Moragas, and J Ocaña, and C Schindléry

Two multicentre, open comparative trials were carried out by seven dermatologists in Spain and Yugoslavia in 220 evaluable patients with acute superficial skin infections. In these trials halometasone/triclosan cream showed an overall success rate ('good' and 'very good' results) of 84% as against 60% obtained with the comparative preparations. With regard to therapeutic effect halometasone/triclosan cream proved significantly superior to fluocinolone acetonide/neomycin cream (p less than 0.001) and yielded a higher overall success rate, although not statistically significant, than that observed with fluprednylidene acetate/gentamicin/chlorohydroxyquinoline cream (75% versus 57%). The halometasone/triclosan cream was well tolerated: the incidence of unwanted effects was significantly lower (p less than 0.05) than that with fluocinolone acetonide/neomycin cream and equal to that with fluprednylidene acetate/gentamicin/chlorohydroxyquinoline cream.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009355 Neomycin Aminoglycoside antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C, and acts by inhibiting translation during protein synthesis. Fradiomycin Sulfate,Neomycin Palmitate,Neomycin Sulfate
D010647 Phenyl Ethers Ethers that are linked to a benzene ring structure. Diphenyl Oxide,Diphenyl Oxides,Diphenyl Ethers,Ethers, Diphenyl,Ethers, Phenyl,Oxide, Diphenyl,Oxides, Diphenyl
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005260 Female Females
D005446 Fluocinolone Acetonide A glucocorticoid derivative used topically in the treatment of various skin disorders. It is usually employed as a cream, gel, lotion, or ointment. It has also been used topically in the treatment of inflammatory eye, ear, and nose disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732) Fluortriamcinolone Acetonide,Alvadermo,Capex,Co-Fluocin,Cortiespec,Derma-Smooth FS,Flucinar,Fluocid,Fluodermo,Fluonid,Fluotrex,Flurosyn,Flusolgen,Gelidina,Jellin,Jellisoft,Synalar,Synalar-HP,Synamol,Synemol,Acetonide, Fluocinolone,Acetonide, Fluortriamcinolone,Co Fluocin,Derma Smooth FS,Synalar HP
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations

Related Publications

A Aliaga, and A Castells, and D Kriznik, and J Lalosević, and J Marrón, and J Moragas, and J Ocaña, and C Schindléry
An overview of international clinical trials with halometasone cream.
January 1983, The Journal of international medical research,
A Aliaga, and A Castells, and D Kriznik, and J Lalosević, and J Marrón, and J Moragas, and J Ocaña, and C Schindléry
A comparative multicentre trial of halometasone/triclosan cream and diflucortolone valerate/chlorquinaldol cream in the treatment of acute dermatomycoses.
January 1983, The Journal of international medical research,
A Aliaga, and A Castells, and D Kriznik, and J Lalosević, and J Marrón, and J Moragas, and J Ocaña, and C Schindléry
A comparative multicentre trial of halometasone/triclosan cream and betamethasone dipropionate/gentamicin sulphate cream in the treatment of infected acute eczematous dermatitis.
January 1983, The Journal of international medical research,
A Aliaga, and A Castells, and D Kriznik, and J Lalosević, and J Marrón, and J Moragas, and J Ocaña, and C Schindléry
Clinical experience with 0.05% halometasone/1% triclosan cream in the treatment of acute infected and infection-prone eczema in Egypt.
January 1987, The Journal of international medical research,
A Aliaga, and A Castells, and D Kriznik, and J Lalosević, and J Marrón, and J Moragas, and J Ocaña, and C Schindléry
An overview of international clinical trials with halometasone ointment in chronic eczematous dermatoses.
January 1983, The Journal of international medical research,
A Aliaga, and A Castells, and D Kriznik, and J Lalosević, and J Marrón, and J Moragas, and J Ocaña, and C Schindléry
[Treatment of acute episodes of atopic dermatitis. Double-blind comparative study with 0.05% halometasone cream versus 0.25% prednicarbate cream].
December 1991, Fortschritte der Medizin,
A Aliaga, and A Castells, and D Kriznik, and J Lalosević, and J Marrón, and J Moragas, and J Ocaña, and C Schindléry
[Superficial skin infections and bacterial dermohypodermitis].
August 2014, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
A Aliaga, and A Castells, and D Kriznik, and J Lalosević, and J Marrón, and J Moragas, and J Ocaña, and C Schindléry
Evaluation of halometasone cream in the treatment of paediatric patients with acute eczematous dermatoses.
January 1983, The Journal of international medical research,
A Aliaga, and A Castells, and D Kriznik, and J Lalosević, and J Marrón, and J Moragas, and J Ocaña, and C Schindléry
Superficial bacterial and fungal infections of the skin.
January 1990, Advances in pediatric infectious diseases,
A Aliaga, and A Castells, and D Kriznik, and J Lalosević, and J Marrón, and J Moragas, and J Ocaña, and C Schindléry
Trimethoprim-polymyxin B sulphate cream compared with fusidic acid cream in the treatment of superficial bacterial infection of the skin.
January 1990, The Journal of international medical research,
Copied contents to your clipboard!